Evidence map›Paper›PMID 31287417›Full record

ArticleeLife2019

Genetic interactions of G-quadruplexes in humans.

Katherine G Zyner, Darcie S Mulhearn, Santosh Adhikari, Sergio Martínez Cuesta, Marco Di Antonio, Nicolas Erard, Gregory J Hannon, David Tannahill, Shankar Balasubramanian

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 152 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. G-quadruplex stabilization induces DNA breaks in pericentromeric repetitive DNA sequences in B lymphocytes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. G-quadruplex DNA structure is a positive regulator ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Katherine G Zyner *Cancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom.ORCID 0000-0002-4997-0150
Darcie S Mulhearn *Cancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom.
Santosh AdhikariDepartment of Chemistry, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-1501-2106
Sergio Martínez CuestaCancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom.ORCID 0000-0001-9806-2805
Marco Di AntonioDepartment of Chemistry, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-7321-1867
Nicolas ErardCancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom.
Gregory J HannonCancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom.ORCID 0000-0003-4021-3898
David TannahillCancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom.ORCID 0000-0002-3811-6864
Shankar BalasubramanianCancer Research United Kingdom Cambridge Institute, Cambridge, United Kingdom.ORCID 0000-0002-0281-5815
Cancer Research UK Cambridge Center · GBUniversity of Cambridge · GB

Funding

Cancer Research UK 18618Cancer Research UK 19836Cancer Research UK 21143Cancer Research UK A21143Cancer Research UK C14303/A17197Cancer Research UK C9681/A18618Wellcome Trust
6 · The paper itself

Abstract

G-quadruplexes (G4) are alternative nucleic acid structures involved in transcription, translation and replication. Aberrant G4 formation and stabilisation is linked to genome instability and cancer. G4 ligand treatment disrupts key biological processes leading to cell death. To discover genes and pathways involved with G4s and gain mechanistic insights into G4 biology, we present the first unbiased genome-wide study to systematically identify human genes that promote cell death when silenced by shRNA in the presence of G4-stabilising small molecules. Many novel genetic vulnerabilities were revealed opening up new therapeutic possibilities in cancer, which we exemplified by an orthogonal pharmacological inhibition approach that phenocopies gene silencing. We find that targeting the WEE1 cell cycle kinase or USP1 deubiquitinase in combination with G4 ligand treatment enhances cell killing. We also identify new genes and pathways regulating or interacting with G4s and demonstrate that the DDX42 DEAD-box helicase is a newly discovered G4-binding protein.

Indexed as

Genetic TestingG-QuadruplexesApoptosisCell Line, TumorCell NucleusGenes, NeoplasmGenome, HumanHumansLigandsNeoplasm ProteinsNeoplasmsRNA, Small InterferingSignal TransductionLigandsNeoplasm ProteinsRNA, Small Interferingbiochemistrycancerchemical biologychromosomesG4gene expressiongenetic vulnerabilityG-quadruplexG-quadruplex ligandshumannucleic acid structure

Identifiers

PMID31287417
PMCPMC6615864
OpenAlexW2954390038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.